{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:42:52Z","timestamp":1781898172584,"version":"3.54.5"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"PIQUR Therapeutics"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.neuropharm.2019.107812","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T05:53:32Z","timestamp":1571032412000},"page":"107812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Brain-penetrant PQR620 mTOR and PQR530 PI3K\/mTOR inhibitor reduce huntingtin levels in cell models of HD"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6669-9676","authenticated-orcid":false,"given":"Elisabeth","family":"Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriano","family":"Fabbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Rageot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Beaufils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3349-4281","authenticated-orcid":false,"given":"Matthias P.","family":"Wymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Rischert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Hillmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huu Phuc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107812_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nlm.2007.08.007","article-title":"The role of protein synthesis during the labile phases of memory: revisiting the skepticism","volume":"89","author":"Alberini","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2019.107812_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002906","article-title":"Disruption of neuronal autophagy by infected microglia results in neurodegeneration","volume":"3","author":"Alirezaei","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107812_bib3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107812_bib4","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","article-title":"Huntingtin aggregation and toxicity in Huntington's disease","volume":"361","author":"Bates","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2019.107812_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/cells6030025","article-title":"Assessment of autophagy in neurons and brain tissue","volume":"6","author":"Benito-Cuesta","year":"2017","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2019.107812_bib6","first-page":"240","article-title":"The phosphatidylinositol 3\u2010kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes","volume":"243","author":"Blommaart","year":"1997","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2019.107812_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: mechanistic insights","volume":"12","author":"Bove","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neuropharm.2018.08.002","article-title":"The novel, catalytic mTORC1\/2 inhibitor PQR620 and the PI3K\/mTORC1\/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy","volume":"140","author":"Brandt","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107812_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases","volume":"416","author":"Bucciantini","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107812_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4161\/auto.6.3.11261","article-title":"Activation of autophagy and Akt\/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia","volume":"6","author":"Carloni","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2019.107812_bib11","doi-asserted-by":"crossref","first-page":"33791","DOI":"10.1074\/jbc.M204861200","article-title":"Glycogen synthase kinase-3\u03b2 inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation","volume":"277","author":"Carmichael","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107812_bib12","doi-asserted-by":"crossref","first-page":"25485","DOI":"10.1074\/jbc.M501707200","article-title":"Phosphorylation of mammalian target of rapamycin (mTOR) at ser-2448 is mediated by p70S6 kinase","volume":"280","author":"Chiang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107812_bib13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.celrep.2018.03.117","article-title":"Cardiac mTORC1 dysregulation impacts stress adaptation and survival in huntington's disease","volume":"23","author":"Child","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2019.107812_bib14","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"Choo","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib15","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2019.107812_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0955-0674(98)80149-X","article-title":"Mechanisms and consequences of activation of protein kinase B\/Akt","volume":"10","author":"Downward","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.275.5300.661","article-title":"Regulation of neuronal survival by the serine-threonine protein kinase Akt","volume":"275","author":"Dudek","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2019.107812_bib18","doi-asserted-by":"crossref","first-page":"11051","DOI":"10.1073\/pnas.0604548103","article-title":"A network of protein interactions determines polyglutamine toxicity","volume":"103","author":"Duennwald","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107812_bib19","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1091\/mbc.01-12-0584","article-title":"Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake","volume":"13","author":"Edinger","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neuropharm.2019.107812_bib20","series-title":"Feeding Schedule and Proteolysis Regulate Autophagic Clearance of Mutant Huntingtin","author":"Ehrnhoefer","year":"2017"},{"key":"10.1016\/j.neuropharm.2019.107812_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1073858410390378","article-title":"Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease","volume":"17","author":"Ehrnhoefer","year":"2011","journal-title":"The Neuroscientist"},{"key":"10.1016\/j.neuropharm.2019.107812_bib22","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1097\/TP.0000000000001933","article-title":"Influence of the novel ATP-competitive dual mTORC1\/2 inhibitor AZD2014 on immune cell populations and heart allograft rejection","volume":"101","author":"Fantus","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.neuropharm.2019.107812_bib23","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-5-26","article-title":"The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6\/2 mouse model of Huntington's disease","volume":"5","author":"Fox","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2019.107812_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2019.107812_bib26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/iub.187","article-title":"GSK\u20103: a key player in neurodegeneration and memory","volume":"61","author":"Giese","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neuropharm.2019.107812_bib27","doi-asserted-by":"crossref","first-page":"50514","DOI":"10.1074\/jbc.M309348200","article-title":"Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells","volume":"278","author":"Gines","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107812_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.redox.2013.12.013","article-title":"Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease","volume":"2","author":"Giordano","year":"2014","journal-title":"Redox Biology"},{"key":"10.1016\/j.neuropharm.2019.107812_bib29","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awr333","article-title":"Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum","volume":"135","author":"Grondin","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2019.107812_bib30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107812_bib31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107812_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/NMM:4:1-2:21","article-title":"Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases","volume":"4","author":"Hashimoto","year":"2003","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.neuropharm.2019.107812_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddq285","article-title":"Early autophagic response in a novel knock-in model of Huntington disease","volume":"19","author":"Heng","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2019.107812_bib34","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2017-159","article-title":"Abstract 159: pharmacological characterization of the selective, orally bioavailable, potent dual PI3K\/mTORC1\/2 inhibitor PQR530","volume":"77","author":"Hillmann","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2019.107812_bib35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","article-title":"Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes","volume":"48","author":"Hurlbert","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2019.107812_bib36","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","article-title":"Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release","volume":"10","author":"Jana","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2019.107812_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm.2091","article-title":"Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor","volume":"16","author":"Janes","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2019.107812_bib38","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nature07195","article-title":"Misfolded proteins partition between two distinct quality control compartments","volume":"454","author":"Kaganovich","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107812_bib39","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1523\/JNEUROSCI.20-19-07268.2000","article-title":"Huntingtin expression stimulates endosomal\u2013lysosomal activity, endosome tubulation, and autophagy","volume":"20","author":"Kegel","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib40","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1124\/mol.107.043398","article-title":"Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis","volume":"73","author":"King","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","article-title":"New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins","volume":"56","author":"Ko","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2019.107812_bib42","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107812_bib43","doi-asserted-by":"crossref","first-page":"14489","DOI":"10.1073\/pnas.0701311104","article-title":"Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration","volume":"104","author":"Komatsu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2019.107812_bib44","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.107812_bib45","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ncb0910-836","article-title":"Selective autophagy: ubiquitin-mediated recognition and beyond","volume":"12","author":"Kraft","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015245","article-title":"Formation and toxicity of soluble polyglutamine oligomers in living cells","volume":"5","author":"Lajoie","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107812_bib47","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2019.107812_bib49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2014.12.019","article-title":"Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes","volume":"85","author":"Lee","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.107812_bib50","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","article-title":"Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice","volume":"21","author":"Li","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib51","doi-asserted-by":"crossref","first-page":"31380","DOI":"10.1074\/jbc.M606603200","article-title":"Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions","volume":"281","author":"Liu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107812_bib52","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.neuron.2012.06.001","article-title":"\"Huntingtin holiday\". Progress toward an antisense therapy for Huntington's disease","volume":"74","author":"Lu","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.107812_bib53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Ma","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","article-title":"Autophagy in Huntington disease and huntingtin in autophagy","volume":"38","author":"Martin","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib55","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuropharm.2019.107812_bib57","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1523\/JNEUROSCI.21-06-01830.2001","article-title":"Tissue-specific proteolysis of huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum","volume":"21","author":"Mende-Mueller","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/awp292","article-title":"Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3","volume":"133","author":"Menzies","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2019.107812_bib59","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1093\/hmg\/ddg295","article-title":"Pathogenesis of polyglutamine disorders: aggregation revisited","volume":"2","author":"Michalik","year":"2003","journal-title":"Hum Mol Genet 12 Spec No"},{"key":"10.1016\/j.neuropharm.2019.107812_bib60","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2019.107812_bib61","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107812_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.276","article-title":"Mechanisms of RNA-induced toxicity in CAG repeat disorders","volume":"4","author":"Nalavade","year":"2013","journal-title":"Cell Death Disease"},{"key":"10.1016\/j.neuropharm.2019.107812_bib63","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1086\/301846","article-title":"Laboratory guidelines for Huntington disease genetic testing","volume":"62","author":"Nance","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2019.107812_bib64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study","volume":"64","author":"Nixon","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib65","doi-asserted-by":"crossref","first-page":"16889","DOI":"10.1073\/pnas.1420103111","article-title":"Potential function for the Huntingtin protein as a scaffold for selective autophagy","volume":"111","author":"Ochaba","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib66","first-page":"14338","volume":"vol. 8","author":"Palmieri","year":"2017"},{"key":"10.1016\/j.neuropharm.2019.107812_bib67","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nature05853","article-title":"HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS","volume":"447","author":"Pandey","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107812_bib68","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Pankiv","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107812_bib69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biochi.2007.08.014","article-title":"Regulation of macroautophagy by mTOR and Beclin 1 complexes","volume":"90","author":"Pattingre","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.neuropharm.2019.107812_bib70","doi-asserted-by":"crossref","first-page":"41032","DOI":"10.1074\/jbc.M205809200","article-title":"Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization","volume":"277","author":"Poirier","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107812_bib71","doi-asserted-by":"crossref","first-page":"ra103","DOI":"10.1126\/scisignal.2005633","article-title":"Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease","volume":"7","author":"Pryor","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2019.107812_bib72","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2017-140","article-title":"Abstract 140: discovery and biological evaluation of PQR530, a highly potent dual pan-PI3K\/mTORC1\/2 inhibitor","volume":"77","author":"Rageot","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2019.107812_bib73","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.8b01262","article-title":"Discovery and preclinical characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a highly potent and selective mTORC1\/2 inhibitor for cancer and neurological disorders","author":"Rageot","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2019.107812_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/11.9.1107","article-title":"Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy","volume":"11","author":"Ravikumar","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2019.107812_bib75","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.mam.2006.08.008","article-title":"Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?","volume":"27","author":"Ravikumar","year":"2006","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.neuropharm.2019.107812_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2019.107812_bib77","doi-asserted-by":"crossref","first-page":"ra42","DOI":"10.1126\/scisignal.2002790","article-title":"The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis","volume":"5","author":"Roczniak-Ferguson","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2019.107812_bib78","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1471-4159.2011.07435.x","article-title":"Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model","volume":"119","author":"Roscic","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.107812_bib79","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2019.107812_bib80","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib81","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"Rubinsztein","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107812_bib82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4161\/auto.1.1.1513","article-title":"Autophagy and its possible roles in nervous system diseases, damage and repair","volume":"1","author":"Rubinsztein","year":"2005","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2019.107812_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/ncb3101","article-title":"Huntingtin functions as a scaffold for selective macroautophagy","volume":"17","author":"Rui","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib84","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/15548627.2015.1039219","article-title":"HTT\/Huntingtin in selective autophagy and Huntington disease: a foe or a friend within?","volume":"11","author":"Rui","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2019.107812_bib85","doi-asserted-by":"crossref","first-page":"ra36","DOI":"10.1126\/scisignal.2000308","article-title":"Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia","volume":"2","author":"Santini","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2019.107812_bib86","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2019.107812_bib87","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2008.110","article-title":"Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies","volume":"16","author":"Sarkar","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2019.107812_bib88","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/j.1742-4658.2008.06562.x","article-title":"Huntington's disease: degradation of mutant huntingtin by autophagy","volume":"275","author":"Sarkar","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2019.107812_bib89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2019.107812_bib90","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2990.2011.01220.x","article-title":"Cellular protein quality control and the evolution of aggregates in spinocerebellar ataxia type 3 (SCA3)","volume":"38","author":"Seidel","year":"2012","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib91","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","article-title":"A novel GSK-3\u03b2 inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo","volume":"35","author":"Sereno","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2019.107812_bib92","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2019.107812_bib93","doi-asserted-by":"crossref","first-page":"14474","DOI":"10.1074\/jbc.M600364200","article-title":"Regulation of intracellular accumulation of mutant huntingtin by beclin 1","volume":"281","author":"Shibata","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107812_bib94","doi-asserted-by":"crossref","first-page":"16880","DOI":"10.1038\/s41598-017-17275-4","article-title":"Reduced cell size, chromosomal aberration and altered proliferation rates are characteristics and confounding factors in the STHdh cell model of Huntington disease","volume":"7","author":"Singer","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2019.107812_bib95","doi-asserted-by":"crossref","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107812_bib96","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","article-title":"Expression of A53T mutant but not wild-type \u03b1-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death","volume":"21","author":"Stefanis","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib97","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.4161\/cc.9.17.12718","article-title":"Does Huntingtin play a role in selective macroautophagy?","volume":"9","author":"Steffan","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuropharm.2019.107812_bib98","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4161\/auto.22558","article-title":"Activation of autophagy in cells with abnormal karyotype","volume":"9","author":"Stingele","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2019.107812_bib99","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0959-8049(16)32696-X","article-title":"The novel mTORC1\/2 inhibitor PQR620 has in vitro and in vivo activity in lymphomas","volume":"69","author":"Tarantelli","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neuropharm.2019.107812_bib100","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/cancers11060775","article-title":"The novel TORC1\/2 kinase inhibitor PQR620 has anti-tumor activity in lymphomas as a single agent and in combination with venetoclax","volume":"11","author":"Tarantelli","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.neuropharm.2019.107812_bib101","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2019.107812_bib102","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2019.107812_bib103","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib104","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2016.04.041","article-title":"Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro","volume":"108","author":"Walter","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107812_bib105","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1073\/pnas.1524575113","article-title":"Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib106","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2019.107812_bib107","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2261-06.2006","article-title":"Induction of autophagy in axonal dystrophy and degeneration","volume":"26","author":"Wang","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib108","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington's disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib109","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1073\/pnas.0709695104","article-title":"Small molecule regulators of autophagy identified by an image-based high-throughput screen","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2019.107812_bib110","first-page":"15","article-title":"mTOR inhibitors at a glance","volume":"7","author":"Zheng","year":"2015","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107812_bib111","first-page":"8","article-title":"Current development of the second generation of mTOR inhibitors as anticancer agents","volume":"31","author":"Zhou","year":"2012","journal-title":"Chin. J. Canc."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081930379X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081930379X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T16:34:39Z","timestamp":1664642079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081930379X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":111,"alternative-id":["S002839081930379X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107812","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain-penetrant PQR620 mTOR and PQR530 PI3K\/mTOR inhibitor reduce huntingtin levels in cell models of HD","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107812"}}